Artiva Biotherapeutics announces 2026 annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Artiva Biotherapeutics has scheduled its 2026 annual meeting of stockholders for September 8, 2026, in San Diego, California. The agenda includes consideration of shareholder nominations to the board of directors and other shareholder business. Stockholder proposals intended for inclusion in proxy materials must be received by August 1, 2026.
- Artiva Biotherapeutics set its 2026 annual meeting of stockholders for Sept. 8, 2026 in San Diego, California. * The meeting will cover shareholder nominations to the board of directors and other shareholder business submitted for consideration. * Stockholder proposals for inclusion in the proxy materials must be received by Aug. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-312560), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here